当前位置: X-MOL 学术Diabetol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register
Diabetologia ( IF 8.4 ) Pub Date : 2021-11-22 , DOI: 10.1007/s00125-021-05613-1
Feifei Cheng 1 , Andrea O Luk 1, 2, 3 , Hongjiang Wu 1 , Claudia H T Tam 1, 2, 3 , Cadmon K P Lim 1, 3 , Baoqi Fan 1, 2 , Guozhi Jiang 1 , Luke Carroll 4 , Aimin Yang 1, 2 , Eric S H Lau 1 , Alex C W Ng 1 , Heung Man Lee 1, 3 , Elaine Chow 1, 2 , Alice P S Kong 1, 2, 3 , Anthony C Keech 4 , Mugdha V Joglekar 4, 5 , Wing Yee So 1, 2 , Anandwardhan A Hardikar 4, 5 , Juliana C N Chan 1, 2, 3, 6 , Alicia J Jenkins 1, 4 , Ronald C W Ma 1, 2, 3, 4, 6
Affiliation  

Aims/hypothesis

Few large-scale prospective studies have investigated associations between relative leucocyte telomere length (rLTL) and kidney dysfunction in individuals with type 2 diabetes. We examined relationships between rLTL and incident end-stage kidney disease (ESKD) and the slope of eGFR decline in Chinese individuals with type 2 diabetes.

Methods

We studied 4085 Chinese individuals with type 2 diabetes observed between 1995 and 2007 in the Hong Kong Diabetes Register with stored baseline DNA and available follow-up data. rLTL was measured using quantitative PCR. ESKD was diagnosed based on the ICD-9 code and eGFR.

Results

In this cohort (mean ± SD age 54.3 ± 12.6 years) followed up for 14.1 ± 5.3 years, 564 individuals developed incident ESKD and had shorter rLTL at baseline (4.2 ± 1.2 vs 4.7 ± 1.2, p < 0.001) than the non-progressors (n = 3521). On Cox regression analysis, each ∆∆Ct decrease in rLTL was associated with an increased risk of incident ESKD (HR 1.21 [95% CI 1.13, 1.30], p < 0.001); the association remained significant after adjusting for baseline age, sex, HbA1c, lipids, renal function and other risk factors (HR 1.11 [95% CI 1.03, 1.19], p = 0.007). Shorter rLTL at baseline was associated with rapid decline in eGFR (>4% per year) during follow-up (unadjusted OR 1.22 [95% CI 1.15, 1.30], p < 0.001; adjusted OR 1.09 [95% CI 1.01, 1.17], p = 0.024).

Conclusions/interpretation

rLTL is independently associated with incident ESKD and rapid eGFR loss in individuals with type 2 diabetes. Telomere length may be a useful biomarker for the progression of kidney function and ESKD in type 2 diabetes.

Graphical abstract

更新日期:2022-01-08
down
wechat
bug